Global ?-Nicotinamide Mononucleotide (NMN) Market Research Report 2026(Status and Outlook)
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.NMN is a precursor of nicotinamide adenine dinucleotide (NAD+), which plays a vital role in cell metabolism and energy production. As we age, the level of NAD+ in the human body gradually decreases, resulting in weakened cell metabolism, which in turn triggers a series of aging-related diseases. Therefore, increasing the level of NAD+ in the body by supplementing NMN has become a new way to fight aging and maintain good health.With the general improvement of global health awareness and continuous breakthroughs in scientific research and technology, the growth momentum of the NMN market will continue to increase. In the future, the NMN market will achieve a deeper cross-border integration with other health industries such as biotechnology, precision medicine, and nutritional supplements, giving rise to a series of innovative products and service models to meet consumers' more personalized and precise health needs.At present, nicotinamide mononucleotide (NMN) is still in the development stage. There are not many manufacturers in the global market, and consumers have weak awareness of its use, especially in developing countries. The demand is lower than that in developed countries around the world, but the demand in developing countries is growing rapidly. Leading giants have proposed expansion plans and increased production bases.Nicotinamide mononucleotide (NMN) core manufacturers include GeneHarbor, Mirailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production area, accounting for about 84% of the global market share, followed by North America and Japan. The downstream applications of nicotinamide mononucleotide include health products, cosmetics, etc. Globally, health products are the largest application market, and raw materials for health products account for 99% of the total sales of nicotinamide mononucleotide in 2023.
The global ?-Nicotinamide Mononucleotide (NMN) market size was estimated at USD 418.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global ?-Nicotinamide Mononucleotide (NMN) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global ?-Nicotinamide Mononucleotide (NMN) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the ?-Nicotinamide Mononucleotide (NMN) market.
Global ?-Nicotinamide Mononucleotide (NMN) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical
Market Segmentation (by Type)
Content ?98%
Content ?98%
Market Segmentation (by Application)
Health Care Products
Cosmetics
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the ?-Nicotinamide Mononucleotide (NMN) Market
Overview of the regional outlook of the ?-Nicotinamide Mononucleotide (NMN) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the ?-Nicotinamide Mononucleotide (NMN) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of ?-Nicotinamide Mononucleotide (NMN), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global ?-Nicotinamide Mononucleotide (NMN) market size was estimated at USD 418.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global ?-Nicotinamide Mononucleotide (NMN) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global ?-Nicotinamide Mononucleotide (NMN) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the ?-Nicotinamide Mononucleotide (NMN) market.
Global ?-Nicotinamide Mononucleotide (NMN) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
ABA Chemical
Market Segmentation (by Type)
Content ?98%
Content ?98%
Market Segmentation (by Application)
Health Care Products
Cosmetics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the ?-Nicotinamide Mononucleotide (NMN) Market
Overview of the regional outlook of the ?-Nicotinamide Mononucleotide (NMN) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the ?-Nicotinamide Mononucleotide (NMN) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of ?-Nicotinamide Mononucleotide (NMN), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of ?-Nicotinamide Mononucleotide (NMN)
1.2 Key Market Segments
1.2.1 ?-Nicotinamide Mononucleotide (NMN) Segment by Type
1.2.2 ?-Nicotinamide Mononucleotide (NMN) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global ?-Nicotinamide Mononucleotide (NMN) Product Life Cycle
3.3 Global ?-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2020-2025)
3.4 Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2020-2025)
3.5 ?-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global ?-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 ?-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
3.8.1 ?-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
3.8.2 Global 5 and 10 Largest ?-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) INDUSTRY CHAIN ANALYSIS
4.1 ?-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global ?-Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to ?-Nicotinamide Mononucleotide (NMN) Market
5.7 ESG Ratings of Leading Companies
6 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2020-2025)
6.3 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Type (2020-2025)
6.4 Global ?-Nicotinamide Mononucleotide (NMN) Price by Type (2020-2025)
7 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Sales by Application (2020-2025)
7.3 Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2025)
7.4 Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2025)
8 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SALES BY REGION
8.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region
8.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.3 North America
8.3.1 North America ?-Nicotinamide Mononucleotide (NMN) Sales by Country
8.3.2 North America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country
8.4.2 Europe ?-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.5.2 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America ?-Nicotinamide Mononucleotide (NMN) Sales by Country
8.6.2 South America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.7.2 Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET PRODUCTION BY REGION
9.1 Global Production of ?-Nicotinamide Mononucleotide (NMN) by Region(2020-2025)
9.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
9.3 Global ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America ?-Nicotinamide Mononucleotide (NMN) Production
9.4.1 North America ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.4.2 North America ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe ?-Nicotinamide Mononucleotide (NMN) Production
9.5.1 Europe ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.5.2 Europe ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan ?-Nicotinamide Mononucleotide (NMN) Production (2020-2025)
9.6.1 Japan ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.6.2 Japan ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China ?-Nicotinamide Mononucleotide (NMN) Production (2020-2025)
9.7.1 China ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.7.2 China ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GeneHarbor
10.1.1 GeneHarbor Basic Information
10.1.2 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.1.3 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.1.4 GeneHarbor Business Overview
10.1.5 GeneHarbor SWOT Analysis
10.1.6 GeneHarbor Recent Developments
10.2 Herbalmax
10.2.1 Herbalmax Basic Information
10.2.2 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.2.3 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.2.4 Herbalmax Business Overview
10.2.5 Herbalmax SWOT Analysis
10.2.6 Herbalmax Recent Developments
10.3 Genex Formulas
10.3.1 Genex Formulas Basic Information
10.3.2 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.3.3 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.3.4 Genex Formulas Business Overview
10.3.5 Genex Formulas SWOT Analysis
10.3.6 Genex Formulas Recent Developments
10.4 Mirailab Bioscience
10.4.1 Mirailab Bioscience Basic Information
10.4.2 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.4.3 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.4.4 Mirailab Bioscience Business Overview
10.4.5 Mirailab Bioscience Recent Developments
10.5 Maac10 Formulas
10.5.1 Maac10 Formulas Basic Information
10.5.2 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.5.3 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.5.4 Maac10 Formulas Business Overview
10.5.5 Maac10 Formulas Recent Developments
10.6 EffePharm
10.6.1 EffePharm Basic Information
10.6.2 EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.6.3 EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.6.4 EffePharm Business Overview
10.6.5 EffePharm Recent Developments
10.7 Bontac
10.7.1 Bontac Basic Information
10.7.2 Bontac ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.7.3 Bontac ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.7.4 Bontac Business Overview
10.7.5 Bontac Recent Developments
10.8 CELFULL
10.8.1 CELFULL Basic Information
10.8.2 CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.8.3 CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.8.4 CELFULL Business Overview
10.8.5 CELFULL Recent Developments
10.9 Kingdomway
10.9.1 Kingdomway Basic Information
10.9.2 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.9.3 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.9.4 Kingdomway Business Overview
10.9.5 Kingdomway Recent Developments
10.10 ABA Chemical
10.10.1 ABA Chemical Basic Information
10.10.2 ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.10.3 ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.10.4 ABA Chemical Business Overview
10.10.5 ABA Chemical Recent Developments
11 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET FORECAST BY REGION
11.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast
11.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country
11.2.3 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
11.2.4 South America ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of ?-Nicotinamide Mononucleotide (NMN) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of ?-Nicotinamide Mononucleotide (NMN) by Type (2026-2035)
12.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of ?-Nicotinamide Mononucleotide (NMN) by Type (2026-2035)
12.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Forecast by Application (2026-2035)
12.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) Forecast by Application
12.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of ?-Nicotinamide Mononucleotide (NMN)
1.2 Key Market Segments
1.2.1 ?-Nicotinamide Mononucleotide (NMN) Segment by Type
1.2.2 ?-Nicotinamide Mononucleotide (NMN) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global ?-Nicotinamide Mononucleotide (NMN) Product Life Cycle
3.3 Global ?-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2020-2025)
3.4 Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2020-2025)
3.5 ?-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global ?-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 ?-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
3.8.1 ?-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
3.8.2 Global 5 and 10 Largest ?-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) INDUSTRY CHAIN ANALYSIS
4.1 ?-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global ?-Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to ?-Nicotinamide Mononucleotide (NMN) Market
5.7 ESG Ratings of Leading Companies
6 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2020-2025)
6.3 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Type (2020-2025)
6.4 Global ?-Nicotinamide Mononucleotide (NMN) Price by Type (2020-2025)
7 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Sales by Application (2020-2025)
7.3 Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2025)
7.4 Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2025)
8 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SALES BY REGION
8.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region
8.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.3 North America
8.3.1 North America ?-Nicotinamide Mononucleotide (NMN) Sales by Country
8.3.2 North America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country
8.4.2 Europe ?-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.5.2 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America ?-Nicotinamide Mononucleotide (NMN) Sales by Country
8.6.2 South America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Region
8.7.2 Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET PRODUCTION BY REGION
9.1 Global Production of ?-Nicotinamide Mononucleotide (NMN) by Region(2020-2025)
9.2 Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
9.3 Global ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America ?-Nicotinamide Mononucleotide (NMN) Production
9.4.1 North America ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.4.2 North America ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe ?-Nicotinamide Mononucleotide (NMN) Production
9.5.1 Europe ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.5.2 Europe ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan ?-Nicotinamide Mononucleotide (NMN) Production (2020-2025)
9.6.1 Japan ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.6.2 Japan ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China ?-Nicotinamide Mononucleotide (NMN) Production (2020-2025)
9.7.1 China ?-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
9.7.2 China ?-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GeneHarbor
10.1.1 GeneHarbor Basic Information
10.1.2 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.1.3 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.1.4 GeneHarbor Business Overview
10.1.5 GeneHarbor SWOT Analysis
10.1.6 GeneHarbor Recent Developments
10.2 Herbalmax
10.2.1 Herbalmax Basic Information
10.2.2 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.2.3 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.2.4 Herbalmax Business Overview
10.2.5 Herbalmax SWOT Analysis
10.2.6 Herbalmax Recent Developments
10.3 Genex Formulas
10.3.1 Genex Formulas Basic Information
10.3.2 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.3.3 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.3.4 Genex Formulas Business Overview
10.3.5 Genex Formulas SWOT Analysis
10.3.6 Genex Formulas Recent Developments
10.4 Mirailab Bioscience
10.4.1 Mirailab Bioscience Basic Information
10.4.2 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.4.3 Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.4.4 Mirailab Bioscience Business Overview
10.4.5 Mirailab Bioscience Recent Developments
10.5 Maac10 Formulas
10.5.1 Maac10 Formulas Basic Information
10.5.2 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.5.3 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.5.4 Maac10 Formulas Business Overview
10.5.5 Maac10 Formulas Recent Developments
10.6 EffePharm
10.6.1 EffePharm Basic Information
10.6.2 EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.6.3 EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.6.4 EffePharm Business Overview
10.6.5 EffePharm Recent Developments
10.7 Bontac
10.7.1 Bontac Basic Information
10.7.2 Bontac ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.7.3 Bontac ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.7.4 Bontac Business Overview
10.7.5 Bontac Recent Developments
10.8 CELFULL
10.8.1 CELFULL Basic Information
10.8.2 CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.8.3 CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.8.4 CELFULL Business Overview
10.8.5 CELFULL Recent Developments
10.9 Kingdomway
10.9.1 Kingdomway Basic Information
10.9.2 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.9.3 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.9.4 Kingdomway Business Overview
10.9.5 Kingdomway Recent Developments
10.10 ABA Chemical
10.10.1 ABA Chemical Basic Information
10.10.2 ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Product Overview
10.10.3 ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Product Market Performance
10.10.4 ABA Chemical Business Overview
10.10.5 ABA Chemical Recent Developments
11 ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET FORECAST BY REGION
11.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast
11.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country
11.2.3 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
11.2.4 South America ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of ?-Nicotinamide Mononucleotide (NMN) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global ?-Nicotinamide Mononucleotide (NMN) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of ?-Nicotinamide Mononucleotide (NMN) by Type (2026-2035)
12.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of ?-Nicotinamide Mononucleotide (NMN) by Type (2026-2035)
12.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Forecast by Application (2026-2035)
12.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) Forecast by Application
12.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 4. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Application
Table 5. ?-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Region (M USD)
Table 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global ?-Nicotinamide Mononucleotide (NMN) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ?-Nicotinamide Mononucleotide (NMN) as of 2025)
Table 11. Global Market ?-Nicotinamide Mononucleotide (NMN) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. ?-Nicotinamide Mononucleotide (NMN) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 27. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 28. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2025)
Table 29. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2020-2025)
Table 30. Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2025)
Table 31. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Type (2020-2025)
Table 32. Global ?-Nicotinamide Mononucleotide (NMN) Price (USD/KG) by Type (2020-2025)
Table 33. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application
Table 34. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Application
Table 35. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2025) & (K MT)
Table 36. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2020-2025)
Table 37. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Application (2020-2025) & (M USD)
Table 38. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application (2020-2025)
Table 39. Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2025)
Table 40. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2025) & (K MT)
Table 41. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025)
Table 42. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025) & (M USD)
Table 43. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025)
Table 44. North America ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 45. North America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 47. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025) & (M USD)
Table 50. South America ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 51. South America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025) & (M USD)
Table 54. Global ?-Nicotinamide Mononucleotide (NMN) Production (K MT) by Region(2020-2025)
Table 55. Global ?-Nicotinamide Mononucleotide (NMN) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
Table 57. Global ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GeneHarbor Basic Information
Table 63. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 64. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GeneHarbor Business Overview
Table 66. GeneHarbor SWOT Analysis
Table 67. GeneHarbor Recent Developments
Table 68. Herbalmax Basic Information
Table 69. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 70. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Herbalmax Business Overview
Table 72. Herbalmax SWOT Analysis
Table 73. Herbalmax Recent Developments
Table 74. Genex Formulas Basic Information
Table 75. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 76. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Genex Formulas Business Overview
Table 78. Genex Formulas SWOT Analysis
Table 79. Genex Formulas Recent Developments
Table 80. Mirailab Bioscience Basic Information
Table 81. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 82. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Mirailab Bioscience Business Overview
Table 84. Mirailab Bioscience Recent Developments
Table 85. Maac10 Formulas Basic Information
Table 86. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 87. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Maac10 Formulas Business Overview
Table 89. Maac10 Formulas Recent Developments
Table 90. EffePharm Basic Information
Table 91. EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 92. EffePharm ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. EffePharm Business Overview
Table 94. EffePharm Recent Developments
Table 95. Bontac Basic Information
Table 96. Bontac ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 97. Bontac ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bontac Business Overview
Table 99. Bontac Recent Developments
Table 100. CELFULL Basic Information
Table 101. CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 102. CELFULL ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CELFULL Business Overview
Table 104. CELFULL Recent Developments
Table 105. Kingdomway Basic Information
Table 106. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 107. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Kingdomway Business Overview
Table 109. Kingdomway Recent Developments
Table 110. ABA Chemical Basic Information
Table 111. ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 112. ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. ABA Chemical Business Overview
Table 114. ABA Chemical Recent Developments
Table 115. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global ?-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 4. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Application
Table 5. ?-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Region (M USD)
Table 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global ?-Nicotinamide Mononucleotide (NMN) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ?-Nicotinamide Mononucleotide (NMN) as of 2025)
Table 11. Global Market ?-Nicotinamide Mononucleotide (NMN) Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. ?-Nicotinamide Mononucleotide (NMN) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 27. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 28. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2025)
Table 29. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2020-2025)
Table 30. Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2025)
Table 31. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Type (2020-2025)
Table 32. Global ?-Nicotinamide Mononucleotide (NMN) Price (USD/KG) by Type (2020-2025)
Table 33. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application
Table 34. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Application
Table 35. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2025) & (K MT)
Table 36. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2020-2025)
Table 37. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Application (2020-2025) & (M USD)
Table 38. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application (2020-2025)
Table 39. Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2025)
Table 40. Global ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2025) & (K MT)
Table 41. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025)
Table 42. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025) & (M USD)
Table 43. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025)
Table 44. North America ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 45. North America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 47. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025) & (M USD)
Table 50. South America ?-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 51. South America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025) & (M USD)
Table 54. Global ?-Nicotinamide Mononucleotide (NMN) Production (K MT) by Region(2020-2025)
Table 55. Global ?-Nicotinamide Mononucleotide (NMN) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
Table 57. Global ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China ?-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GeneHarbor Basic Information
Table 63. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 64. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GeneHarbor Business Overview
Table 66. GeneHarbor SWOT Analysis
Table 67. GeneHarbor Recent Developments
Table 68. Herbalmax Basic Information
Table 69. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 70. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Herbalmax Business Overview
Table 72. Herbalmax SWOT Analysis
Table 73. Herbalmax Recent Developments
Table 74. Genex Formulas Basic Information
Table 75. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 76. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Genex Formulas Business Overview
Table 78. Genex Formulas SWOT Analysis
Table 79. Genex Formulas Recent Developments
Table 80. Mirailab Bioscience Basic Information
Table 81. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 82. Mirailab Bioscience ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Mirailab Bioscience Business Overview
Table 84. Mirailab Bioscience Recent Developments
Table 85. Maac10 Formulas Basic Information
Table 86. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 87. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Maac10 Formulas Business Overview
Table 89. Maac10 Formulas Recent Developments
Table 90. EffePharm Basic Information
Table 91. EffePharm ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 92. EffePharm ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. EffePharm Business Overview
Table 94. EffePharm Recent Developments
Table 95. Bontac Basic Information
Table 96. Bontac ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 97. Bontac ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Bontac Business Overview
Table 99. Bontac Recent Developments
Table 100. CELFULL Basic Information
Table 101. CELFULL ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 102. CELFULL ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. CELFULL Business Overview
Table 104. CELFULL Recent Developments
Table 105. Kingdomway Basic Information
Table 106. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 107. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Kingdomway Business Overview
Table 109. Kingdomway Recent Developments
Table 110. ABA Chemical Basic Information
Table 111. ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Product Overview
Table 112. ABA Chemical ?-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. ABA Chemical Business Overview
Table 114. ABA Chemical Recent Developments
Table 115. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2026-2035) & (K MT)
Table 116. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region (2026-2035) & (M USD)
Table 117. North America ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (K MT)
Table 118. North America ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 119. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (K MT)
Table 120. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 121. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2026-2035) & (K MT)
Table 122. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region (2026-2035) & (M USD)
Table 123. South America ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (K MT)
Table 124. South America ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 125. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2026-2035) & (Units)
Table 126. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Country (2026-2035) & (M USD)
Table 127. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2026-2035) & (K MT)
Table 128. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Type (2026-2035) & (M USD)
Table 129. Global ?-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2026-2035) & (USD/KG)
Table 130. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) Forecast by Application (2026-2035)
Table 131. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of ?-Nicotinamide Mononucleotide (NMN)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD), 2025-2035
Figure 5. Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) (2020-2035)
Figure 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global ?-Nicotinamide Mononucleotide (NMN) Product Life Cycle
Figure 13. ?-Nicotinamide Mononucleotide (NMN) Sales Share by Manufacturers in 2025
Figure 14. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers in 2025
Figure 15. ?-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market ?-Nicotinamide Mononucleotide (NMN) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by ?-Nicotinamide Mononucleotide (NMN) Revenue in 2025
Figure 18. Industry Chain Map of ?-Nicotinamide Mononucleotide (NMN)
Figure 19. Global ?-Nicotinamide Mononucleotide (NMN) Market PEST Analysis
Figure 20. Global ?-Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Type
Figure 27. Sales Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type (2020-2025)
Figure 28. Sales Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type in 2025
Figure 29. Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type (2020-2025)
Figure 30. Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application
Figure 33. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2020-2025)
Figure 34. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2025
Figure 35. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application (2020-2025)
Figure 36. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application in 2025
Figure 37. Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2025)
Figure 38. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025)
Figure 39. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025)
Figure 40. North America ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2024
Figure 43. North America ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country in 2024
Figure 45. U.S. ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico ?-Nicotinamide Mononucleotide (NMN) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico ?-Nicotinamide Mononucleotide (NMN) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2024
Figure 53. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size by Country in 2024
Figure 55. Germany ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2024
Figure 67. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size by Region in 2024
Figure 68. China ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (K MT)
Figure 79. South America ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2024
Figure 80. South America ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (M USD)
Figure 81. South America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country in 2024
Figure 82. Brazil ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size by Region in 2024
Figure 92. Saudi Arabia ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2020-2025)
Figure 103. North America ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 106. China ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global ?-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Type (2026-2035)
Figure 111. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2026-2035)
Figure 112. Global ?-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of ?-Nicotinamide Mononucleotide (NMN)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD), 2025-2035
Figure 5. Global ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) (2020-2035)
Figure 6. Global ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. ?-Nicotinamide Mononucleotide (NMN) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global ?-Nicotinamide Mononucleotide (NMN) Product Life Cycle
Figure 13. ?-Nicotinamide Mononucleotide (NMN) Sales Share by Manufacturers in 2025
Figure 14. Global ?-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers in 2025
Figure 15. ?-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market ?-Nicotinamide Mononucleotide (NMN) Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by ?-Nicotinamide Mononucleotide (NMN) Revenue in 2025
Figure 18. Industry Chain Map of ?-Nicotinamide Mononucleotide (NMN)
Figure 19. Global ?-Nicotinamide Mononucleotide (NMN) Market PEST Analysis
Figure 20. Global ?-Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Type
Figure 27. Sales Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type (2020-2025)
Figure 28. Sales Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type in 2025
Figure 29. Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type (2020-2025)
Figure 30. Market Share of ?-Nicotinamide Mononucleotide (NMN) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application
Figure 33. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2020-2025)
Figure 34. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2025
Figure 35. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application (2020-2025)
Figure 36. Global ?-Nicotinamide Mononucleotide (NMN) Market Share by Application in 2025
Figure 37. Global ?-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2025)
Figure 38. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2025)
Figure 39. Global ?-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2025)
Figure 40. North America ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2024
Figure 43. North America ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country in 2024
Figure 45. U.S. ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada ?-Nicotinamide Mononucleotide (NMN) Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada ?-Nicotinamide Mononucleotide (NMN) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico ?-Nicotinamide Mononucleotide (NMN) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico ?-Nicotinamide Mononucleotide (NMN) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2024
Figure 53. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe ?-Nicotinamide Mononucleotide (NMN) Market Size by Country in 2024
Figure 55. Germany ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (K MT)
Figure 66. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2024
Figure 67. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Market Size by Region in 2024
Figure 68. China ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (K MT)
Figure 79. South America ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2024
Figure 80. South America ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (M USD)
Figure 81. South America ?-Nicotinamide Mononucleotide (NMN) Market Size by Country in 2024
Figure 82. Brazil ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa ?-Nicotinamide Mononucleotide (NMN) Market Size by Region in 2024
Figure 92. Saudi Arabia ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa ?-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa ?-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2020-2025)
Figure 103. North America ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 106. China ?-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 107. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global ?-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global ?-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global ?-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Type (2026-2035)
Figure 111. Global ?-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2026-2035)
Figure 112. Global ?-Nicotinamide Mononucleotide (NMN) Market Share Forecast by Application (2026-2035)
